Congratulations to @gardp.bsky.social! Great to see this recognition for your organization's incredible work driving forward global access to new treatments addressing #AMR. Proud to have you as a GHTC member!

An trial testing a nasal spray vaccine for bird flu found that it generated a strong immune response in rodents, a first step toward a vaccine capable of slowing the spread of the flu, which has been spreading globally among animal populations in recent years. www.ghtcoalition.org/blog/researc...

Are you interested in #HIVcure research and live in the United States? The #Cure Academy offers an opportunity to build knowledge, skills, and a network to advance the #HIV field. Apply before February 13! tinyurl.com/yhrt3fv3

HIV Prevention Pipeline: Products to Watch! From the People’s Research Agenda, see this snapshot of HIV prevention options in development: from bNAbs to vaccines, from next generation #PrEP to multipurpose technologies.

👩 On the International Day of Women and Girls in Science, Astrid Pentz-Murr reflects on how women’s scientific leadership strengthens antibiotic R&D and drives real public health impact. At GARDP, supporting women in science is central to advancing better solutions to #AMR. @astridpm.bsky.social

Women are shaping the discovery, development and delivery of next-generation #malaria interventions. Today, we’re spotlighting six #WomenInScience from MMV’s network making their mark on global health: bit.ly/4apwjBA

💼 CARB-X is hiring a CHIEF OF R&D! This role leads the team that identifies and translates strategic priorities into public funding calls and contributes to pre-award review and investment decisions, as well as post-award support and portfolio transitions. #IDSky 🧪 ➡️ Apply today! bit.ly/3YLyo5V#IDSky

A Phase I study in healthy African adults assessed oxfendazole, a promising option for filarial diseases such as onchocerciasis. The findings suggest that a five day course of 400 mg daily, or 50 mg twice daily, reaches target exposure with low safety concerns. @PLOSNTDs doi.org/10.1002/psp4...

Congratulations to @mmv.org! Great to see this recognition for your incredible work driving forward innovations in malaria. Proud to have you as a GHTC member!

So proud to see @wacihealth.bsky.social's @rosemarymburu.bsky.social recognized in this moment! Rosemary's leadership, courage, and unwavering commitment to health equity and civil society power are in inspiration, wacihealth.org/category/art...

A durable end to #HIV requires prevention options to meet many needs. Today’s R&D pipeline of non-vaccine products includes pills, rings, gels, films & long-acting injectable #ARVs. This diverse pipeline needs sustained investment to fulfill its promise. buff.ly/ZGHDdvs

In 2025, GHTC launched new members-only services, including a speaker series, and provided timely, contextualized intelligence to help our community navigate a rapidly shifting and often opaque policy environment. 🔗Learn more about GHTC's impact in 2025: www.ghtcoalition.org/documents/pd...

Women scientists are advancing transformative research in #HIV, #TB, & #malaria. Expanding gender diversity in teams, supporting early‑career scientists, and opening paths to leadership helps ensure #GlobalHealth innovation serves everyone. #February11 www.ghtcoalition.org/blog/celebra...

Population Council announced that it has executed an agreement for the NES/T male contraceptive gel, transferring the program to Contraline, which will lead late development toward potential regulatory approval as the first reversible contraceptive drug for men. www.ghtcoalition.org/blog/researc...

In 2025, WHO launched a new streamlined prequalification process and launched strategies on clinical trial strengthening and climate and health, influenced by GHTC's engagement and education with key stakeholders. 🔗Learn more about GHTC's impact in 2025: www.ghtcoalition.org/documents/pd...

A Phase 2 trial on antimalarial use in early pregnancy—co-led by three women investigators—could transform care for this excluded group and set a precedent for more inclusive research, illustrating how gender‑diverse research teams drive more inclusive science. www.ghtcoalition.org/blog/celebra...

A new study has found that five human cases of a mysterious, bat-borne virus in Bangladesh, initially thought to be Nipah virus, were actually caused by another emerging bat-borne virus called Pteropine orthoreovirus. www.ghtcoalition.org/blog/researc...

In 2025, GHTC worked to embed health R&D into multilateral efforts like the G20 agenda and the Pandemic Agreement, which was adopted last year, helping ensure innovation is centered in global preparedness efforts. 🔗Learn more about GHTC's impact in 2025: www.ghtcoalition.org/documents/pd...

A breakthrough drug offers discreet, twice-yearly protection against #HIV —it has the potential to transform global HIV efforts. It’s one of 25+ US-backed tools we brought to the Hill to show how investment in #GlobalHealth R&D pays off. #Innovate4Health www.ghtcoalition.org/blog/gallery...

What's new in #GlobalHealth R&D? 🦇Emerging bat-borne virus 🥼Male contraceptive gel deal 💉Bird flu nasal spray vaccine trial www.ghtcoalition.org/blog/researc...

#Nipah virus is deadly—with no approved treatments or vaccines. A US-backed therapy from @cepi.net in development could be a gamechanger in future outbreaks—one of 25+ lifesaving tools we brought to the Hill to show how smart #GlobalHealth investments pay off. www.ghtcoalition.org/blog/gallery...

Next-gen #malaria vaccines could help turn the tide against this global threat. @path.org & partners are developing new candidates that received key US support. We brought this work and 25+ other tools to the Hill to show how #GlobalHealth investments pay off. www.ghtcoalition.org/blog/gallery...

In 2025, GHTC kept global health R&D front and center, engaging officials at HHS agencies to find ways to support and maintain global health R&D and American research and science more broadly. 🔗Learn more about GHTC's impact in 2025: www.ghtcoalition.org/documents/pd...

From advancing promising #HIV vaccine strategies to trialing #TB vaccine candidates to furthering antimalarials for a long-excluded group, women scientists are at the forefront of science, driving forward tools that could transform the future of #GlobalHealth. www.ghtcoalition.org/blog/celebra...

Life-threatening pregnancy risks often go undetected in low-resource settings, but a portable, AI-powered ultrasound from Philips—developed with US support—is changing that. We showcased it on the Hill among 25+ lifesaving #GlobalHealth tools. #Innovate4Health www.ghtcoalition.org/blog/gallery...

📊 New G-FINDER takeaways out now: Global health R&D funding in 2024 🔗 tinyurl.com/2024GFINDER 💡 We’re moving away from annual reports to shorter analyses published throughout the year. What insights would be most useful to you? Share what you’d like to see from the data in the comments below 👇

CARB-X is awarding US$1.8 million to Chembio Diagnostic Systems, Inc. to develop a rapid point-of-care test for the detection of Immunoglobulin A (IgA) antibodies to diagnose acute infection of Salmonella enterica serovar Typhi. #IDSky 🧪 🔗 Read here: bit.ly/4k5Aqau

TAG’s TB Project Co-Director Mike Frick will give a Grand Rounds talk next week at OHSU’s Center for Global Child Health Research. The talk builds on a two-part One Future podcast conversation about expertise, power, and accountability in research. (1/2)

Momentum continues in the #HIV R&D pipeline— with two early-phase #Vaccine trials, a late-phase monthly #PrEP pill, and advancing #HIVcure research. Stay current on the science shaping prevention and cure in #PxWire:

In 2025, GHTC kept global health R&D on the agenda, educating Congress on the impacts of the foreign aid freeze and engaging with the administration and Congress on efforts to rebuild health R&D programming at the State Department. www.ghtcoalition.org/documents/pd...

Last week, @dndi.org announced a new memorandum of understanding with the African Population and Health Research Center aimed at helping translate African-led research into transformative innovations and health policies. www.ghtcoalition.org/blog/researc...

Fast PCR testing, right where it’s needed. A US-backed platform from Co-Dx detects flu, COVID-19, TB, & more at the point of care—one of 25+ innovations we brought to the Hill to show the real-world impact of smart #GlobalHealth investments. #Innovate4Health www.ghtcoalition.org/blog/gallery...

A tiny sticker with huge impact—this temp monitor from @path.org & Zebra shows if vaccines are heat-damaged, preventing waste & protecting lives. It's one of 25+ tools we took to the Hill to show how smart #GlobalHealth R&D investments pay off. #Innovate4Health www.ghtcoalition.org/blog/gallery...

Spotlight the incredible work of your colleagues. 🌟🔦 Nominations for the 2026 IDSA and HIVMA Society Awards are now open! Submit your nomination now through April 7: https://idsociety.org/about-idsa/society-awards/

The world remains far off track on health-related SDGs, and R&D gaps continue to undermine progress. At #EB158, we urged WHO Member States to ensure sustained investment in new and effective health tools. Our intervention at @who.int 👉 bit.ly/4auqBj2

Despite some progress, the fight against many NTDs remains off track. At #EB158 we urged Member States to fund NTDs, advance R&D, support inclusive research, & tackle climate-sensitive diseases. Our intervention at @who.int 👉 bit.ly/4auqBj2

With support from the Gates Foundation, PATH and partners have been working for nearly 15 years to develop an injectable #rotavirus vaccine. While the candidate we tested was unsuccessful, this bold scientific effort to reimagine rotavirus vaccination leaves a lasting legacy: https://bit.ly/3ZGMuFH

🧫ASM Press presents CMPH—Back to Basics, a free webinar series designed for clinical lab professionals & microbiology technicians! Join the 1st webinar, Respiratory Cultures, Feb. 24 at 12 p.m. ET, presented by Kevin Alby, Ph.D. Learn more & register: asm.social/2NH

The latest issue of #PxWire showcases how access to #LEN for PrEP is accelerating—and why its delivery is moving faster than any #PrEP product before it.

In 2025, GHTC kept global health R&D on the agenda through constructive engagement with Congress, helping influence congressional appropriators to advance interim funding bills protecting global health R&D funding. www.ghtcoalition.org/documents/pd...

Newly shared results from the first blinded, randomized non-inferiority trial comparing one versus two doses of #HPV vaccine show that a single dose provided similar protection to the two-dose schedule. www.ghtcoalition.org/blog/researc...

Vitamin A deficiency puts millions at risk. Biofortified corn from HarvestPlus delivers up to 50% of daily needs for women & children, just one of the US-backed tools we took to the Hill to show how smart #GlobalHealth investments change lives. #Innovate4Health www.ghtcoalition.org/blog/gallery...

GHTC commends Congress for its work to advance a spending package that sustains and strengthens critical US investments in global health R&D, including a new health R&D initiative at the Department of State and funding increases for biomedical research. www.ghtcoalition.org/news/ghtc-ap...

Postpartum hemorrhage kills 70K+ women yearly. @monashuniversity.bsky.social's heat-stable, inhaled oxytocin could save lives where injections aren’t feasible. This US-backed tool is one of 25+ we took to the Hill to show how #GlobalHealth investments pay off. www.ghtcoalition.org/blog/gallery...

In a year of uncertainty and transition, GHTC kept global health R&D on the agenda through constructive engagement with Congress, the administration, and allies around the world. Thank you to our members for your sustained expertise and partnership! www.ghtcoalition.org/documents/pd...

Sino Biological, Inc. recently announced an effort to accelerate the development of critical research tools to support the global scientific community in advancing #Nipah virus research, as new cases of the deadly pathogen have raised international concerns. www.ghtcoalition.org/blog/researc...

Over a million kids get sick with #TB yearly, but meds developed by @tballiance.bsky.social are helping ensure children have appropriate treatment. A breakthrough in global TB care & one of 25+ US-backed tools showing how #GlobalHealth investments save lives. www.ghtcoalition.org/blog/gallery...

Micron's MicroArray needle-free “button” for delivering vaccine/drugs is pain-free and cost-effective. Among 25+ US-backed breakthroughs we presented on the Hill, it highlights the transformative potential of smart #GlobalHealth R&D funding. #Innovate4Health www.ghtcoalition.org/blog/gallery...

What's new in #GlobalHealth R&D? 🔬#Nipah vaccine development 💉Single-dose #HPV vaccine schedule 🥼African-led research capacity-building www.ghtcoalition.org/blog/researc...

A wireless monitoring platform, developed by Sibel and partners and supported by US investments, helps protect moms and babies in real time. It's one of 25+ tools we brought to Capitol Hill to show the impact of smart #GlobalHealth investments. #Innovate4Health www.ghtcoalition.org/blog/gallery...